Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 04/10

Trade details

Type
Insider sale
Amount
$1,048,888.5
Shares · price
1,815 sh · $577.90 a share
Held after
44,219 sh
Trade date
26/04/09
Filed
26/04/10
Days to filing
1 days

Sold 3.9% of holdings

Share of holding sold
3.9%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 03/10~05/09

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Planned sale10b5-1 planUnited Therapeutics

    $113.3M

    Filed 10/01

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $1.1M

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $1M

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $664.2K

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $574.9K

    Filed 09/30